IFS Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
IFS Advisors's IONS Position: Q3 2026 in Review
IFS Advisors opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2026: 100 shares worth $4.46K. The stake represents ﹤0.01% of the portfolio and ranks #372 among its holdings. This is a return to the name: IFS Advisors previously reported a position in IONS as recently as Q4 2022.
IFS Advisors first reported a position in IONS in Q4 2020 and has held it in 7 quarters since. The position peaked at $11K in Q4 2020. 464 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- IFS Advisors held 100 shares of Ionis Pharmaceuticals worth $4.46K as of Q3 2026.
- Ionis Pharmaceuticals was a new IFS Advisors position in Q3 2026.
- Ionis Pharmaceuticals made up ﹤0.01% of IFS Advisors's portfolio in Q3 2026, its #372 holding.
- IFS Advisors first reported a position in Ionis Pharmaceuticals in Q4 2020 and has held it in 7 quarters since.
- IFS Advisors's Ionis Pharmaceuticals position peaked at $11K in Q4 2020.
- 464 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on IFS Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.